Prescription drug · ANDA
Brivaracetam NDC 84386-072
Brivaracetam 100 mg/1 · Tablet, Film coated · Oral · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84386-072-60 | 84386007260 | 60 TABLET, FILM COATED in 1 BOTTLE (84386-072-60)Marketed from Feb 25, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Aurobindo Pharma Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214848
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 84386-072_e1f2bb4b-bf00-4079-8818-5bf1bb678db4SPL ID e1f2bb4b-bf00-4079-8818-5bf1bb678db4SPL set ID 41e218af-048b-4e24-91d2-0b9b262d480cRxCUI 1739768, 1739776UNII U863JGG2IA
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484386007260followed by a unit qualifier and the quantityPackage 84386-0072-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214848
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-070 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-068 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-069 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-071 |